Mbx Biosciences Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$52.48

-2.52 (-4.58%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -10.2% upside

Low Target $32.34

Average Target $47.13

High Target $55.83

Current Price $52.48

Current
$52.48

Target
$47.13

$32.34 $47.13 avg $55.83

Scenario Analysis

Bear Case

$32.34

-38.4%

Low target

Base Case

$47.13

-10.2%

Avg target

Bull Case

$55.83

+6.4%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$72.64

-27.8% from high

52-Week Low

$17.93

+192.8% from low

Target vs 52W High

$47.13

-35.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	36	86%	$1,330.33	-2.5%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	73%	$299.55	+10.0%
MRK Merck & Co. Inc.	Buy	35	74%	$159.27	+8.4%
PFE Pfizer Inc.	Hold	33	39%	$33.90	+13.5%
BMY Bristol-Myers Squibb Co	Hold	34	44%	$174.50	+176.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.3%
ZTS Zoetis Inc	Hold	23	48%	$209.87	+155.6%